Business · 03/09/2004

National Institutes of Health to Grant Exclusive Patent License for Antitumor Macrocyclic Lactones to Reata Discovery, Inc.

The National Institutes of Health is considering granting an exclusive patent license to Reata Discovery, Inc. for the use of antitumor macrocyclic lactones, compositions, and methods of use, with the potential to treat cancer, to a company located in Dallas, TX.